Sterility testing is essential for ensuring pharmaceutical products are free from harmful microorganisms.
Rapid Microbiology Method (RMM) platforms like the Growth Direct® Rapid Sterility (GDRS) system are supported by regulatory agencies with clear validation pathways. GDRS also delivers long-term saving and operational gains that far outweigh initial investment.
What you’ll learn from the infographic
This roadmap infographic shows you how to fast-track sterility testing with:
- Regulatory guidance - FDA, EMA, USP <1223>, EP 5.1.6
- Business case development - ROI, cost savings, faster release
- Proof-of-concept studies - side-by-side data and workflow optimization
- Validation strategies - IQ/OQ/PQ, equivalency, and audit-ready documentation
See how the Growth Direct® Rapid Sterility System helps QC labs cut turnaround to 1–3 days, automate up to 85% of manual steps, and achieve payback in 12–18 months.
If you have additional questions about automating rapid sterility testing for your QC microbiology, click on the Ask a Question button below to contact the supplier.